Status: current, Defined. Date: 31-May 2018. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4077761000168112 | Clarithromycin (Ascent) (clarithromycin 250 mg) tablet (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4077771000168118 | Clarithromycin (Ascent) 250 mg tablet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Clarithromycin (Ascent) 250 mg tablet | Is a | Clarithromycin (Ascent) | true | Inferred relationship | Some | ||
| Clarithromycin (Ascent) 250 mg tablet | Is a | clarithromycin 250 mg tablet | true | Inferred relationship | Some | ||
| Clarithromycin (Ascent) 250 mg tablet | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Clarithromycin (Ascent) 250 mg tablet | has manufactured dose form | film-coated tablet | false | Inferred relationship | Some | ||
| Clarithromycin (Ascent) 250 mg tablet | has unit of use | tablet | true | Inferred relationship | Some | 492946173 | |
| Clarithromycin (Ascent) 250 mg tablet | has intended active ingredient | clarithromycin | true | Inferred relationship | Some | 492946172 | |
| Clarithromycin (Ascent) 250 mg tablet | has Australian BoSS | clarithromycin | true | Inferred relationship | Some | 492946172 | |
| Clarithromycin (Ascent) 250 mg tablet | has manufactured dose form | tablet | true | Inferred relationship | Some |
Reference Sets
Trade product unit of use reference set
FHIR